FDA Clearance Tracker · P970017
SAHARA CLINICAL BONE SONOMETER
Last checked: Nov 20, 2026Latest source record: Mar 12, 1998 (this decision)Source: openFDAMethods & limitations
Decided
Mar 12, 1998
Approved (reclassified)
Time to decision
339 days
Received Apr 7, 1997. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class II
The decision
- FDA number
- P970017
- Device name
- SAHARA CLINICAL BONE SONOMETER
- Applicant
- Hologic, Inc.
- Applicant location
- Bedford, MA
- Received
- Apr 7, 1997
- Decided
- Mar 12, 1998
- Decision
- Approved (reclassified)
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Bone sonometer (MUA)
- Device class
- Class II
- Regulation
- 21 CFR 892.1180
- Specialty
- Radiology & Imaging
FDA's approval statement
As written in FDA's record.
Approval for the Sahara Clinical Bone Sonometer. The intended use of the Sahara Clinical Bone Sonometer is to: Perform a quantitative ultrasound measurement of the calcaneus (heel bone), the results of which can be used in conjunction with other clincal risk factors as an aid to the physician in the diagnosis of osteoporosis and medical conditions leading to reduced bone density, and ultimately in the determination of fracture risk. Sahara measures the speed of sound (SOS, in m/s) and broadband ultrasonic attenuation (BUA, in dB/MHz) of an ultrasound beam passed throught he calcaneus, and combines these results linearly to obtain the Quantitative Ultrasound Index (QUI). The output is also expressed as a T-score and as an estimate of the Bone Mineral Density (BMD, in g/cm2) of the calcaneus as measured by Dual Energy X-ray Absorpiometry (DXA).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MUA (Bone sonometer).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.